Cargando…
The Roles of Imprinted SLC22A18 and SLC22A18AS Gene Overexpression Caused by Promoter CpG Island Hypomethylation as Diagnostic and Prognostic Biomarkers for Non-Small Cell Lung Cancer Patients
Genomic imprinting is a process that involves one gene copy turned-off in a parent-of-origin-dependent manner. The regulation of imprinted genes is broadly dependent on promoter methylation marks, which are frequently associated with both oncogenes and tumor suppressors. The purpose of this study wa...
Autores principales: | Noguera-Uclés, José Francisco, Boyero, Laura, Salinas, Ana, Cordero Varela, Juan Antonio, Benedetti, Johana Cristina, Bernabé-Caro, Reyes, Sánchez-Gastaldo, Amparo, Alonso, Miriam, Paz-Ares, Luis, Molina-Pinelo, Sonia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466018/ https://www.ncbi.nlm.nih.gov/pubmed/32726996 http://dx.doi.org/10.3390/cancers12082075 |
Ejemplares similares
-
Aberrant Methylation of the Imprinted C19MC and MIR371-3 Clusters in Patients with Non-Small Cell Lung Cancer
por: Boyero, Laura, et al.
Publicado: (2023) -
Primary and Acquired Resistance to Immunotherapy in Lung Cancer: Unveiling the Mechanisms Underlying of Immune Checkpoint Blockade Therapy
por: Boyero, Laura, et al.
Publicado: (2020) -
Real-World Analysis of Nivolumab and Atezolizumab Efficacy in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
por: Alonso-García, Miriam, et al.
Publicado: (2022) -
Promoter methylation and downregulation of SLC22A18 are associated with the development and progression of human glioma
por: Chu, Sheng-Hua, et al.
Publicado: (2011) -
Characterization of SLC22A18 as a tumor suppressor and novel biomarker in colorectal cancer
por: Jung, Yeonjoo, et al.
Publicado: (2015)